Brief: Aytu Biopharma Announces Addition Of Fourth Patent License For AR101

Aytu Biopharma

14/09/2022 14:26

Sept 14 (Reuters) - Aytu Biopharma Inc  AYTU.O :
    * AYTU BIOPHARMA ANNOUNCES ADDITION OF FOURTH PATENT LICENSE
FOR
AR101/ENZASTAURIN
    * AYTU BIOPHARMA INC - THE PATENT HAS AN EXPIRY DATE OF
SEPTEMBER
2041, ASSUMING NO PATENT TERM EXTENSIONS

Further company coverage:  AYTU.O 

 ((Reuters.Briefs@thomsonreuters.com;))